Evidence map›Paper›PMID 35335631›Full record

ArticlePathogens (Basel, Switzerland)2022

Beyond CC398: Characterisation of Other Tetracycline and Methicillin-Resistant

Sara Ceballos, Carmen Lozano, Carmen Aspiroz, Laura Ruiz-Ripa, Paula Eguizábal, Allelen Campaña-Burguet, Emilia Cercenado, Ana Isabel López-Calleja, Javier Castillo, Jose Manuel Azcona-Gutiérrez and 7 more

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Detection ofVeterinary sciences · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Sara CeballosArea Bioquímica y Biología Molecular, Universidad de La Rioja, 26006 Logroño, Spain.
Carmen LozanoArea Bioquímica y Biología Molecular, Universidad de La Rioja, 26006 Logroño, Spain.ORCID 0000-0002-0048-9315
Carmen AspirozServicio de Microbiología, Hospital Royo Villanova, 50015 Zaragoza, Spain.
Laura Ruiz-RipaArea Bioquímica y Biología Molecular, Universidad de La Rioja, 26006 Logroño, Spain.
Paula EguizábalArea Bioquímica y Biología Molecular, Universidad de La Rioja, 26006 Logroño, Spain.
Allelen Campaña-BurguetArea Bioquímica y Biología Molecular, Universidad de La Rioja, 26006 Logroño, Spain.
Emilia CercenadoServicio de Microbiología y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, CIBERES (CIBER de Enfermedades Respiratorias), 28007 Madrid, Spain.ORCID 0000-0002-5279-3773
Ana Isabel López-CallejaHospital Universitario Miguel Servet/IIS Aragón, 50009 Zaragoza, Spain.
Javier CastilloHospital Clínico Universitario Lozano Blesa, 50009 Zaragoza, Spain.
Jose Manuel Azcona-GutiérrezHospital San Pedro, 26006 Logroño, Spain.ORCID 0000-0002-0932-9596
Luis TorresHospital San Jorge, 22004 Huesca, Spain.
Jorge CalvoHospital Universitario Marqués de Valdecilla, CIBERINFEC (CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III), 39008 Santander, Spain.ORCID 0000-0003-2898-6599
Carmen MartinComplejo Hospitalario de Navarra, 31008 Pamplona, Spain.
María NavarroHospital Universitari de Vic, 08500 Vic, Spain.
Myriam ZarazagaArea Bioquímica y Biología Molecular, Universidad de La Rioja, 26006 Logroño, Spain.
Carmen TorresArea Bioquímica y Biología Molecular, Universidad de La Rioja, 26006 Logroño, Spain.ORCID 0000-0003-3709-1690
The Study Group Of Clinical LA-Mrsa

Funding

MCIN/ AEI /10.13039/501100011033 of Spain PID2019-106158RB-I00
6 · The paper itself

Abstract

Tetracycline resistance (Tet

Indexed as

CC1CC398MRSAmulticentre studyt127tetracycline resistance

Identifiers

PMID35335631
PMCPMC8956062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.